Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96QS3: Variant p.Arg332His

Homeobox protein ARX
Gene: ARX
Feedback?
Variant information Variant position: help 332 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Histidine (H) at position 332 (R332H, p.Arg332His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In LISX2. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 332 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 562 The length of the canonical sequence.
Location on the sequence: help CLSAGSDSEEGLLKRKQRRY R TTFTSYQLEELERAFQKTHY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CLSAGSDSEEGLLKRKQRRYRTTFTSYQLEELERAFQKTHY

Mouse                         CLSAGSDSEEGLLKRKQRRYRTTFTSYQLEELERAFQKTHY

Rat                           CLSAGSDSEEGLLKRKQRRYRTTFTSYQLEELERAFQKTHY

Zebrafish                     CLSAGSDSEEGMLKRKQRRYRTTFTSYQLEELERAFQKTHY
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 562 Homeobox protein ARX
DNA binding 328 – 387 Homeobox



Literature citations
Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans.
Kitamura K.; Yanazawa M.; Sugiyama N.; Miura H.; Iizuka-Kogo A.; Kusaka M.; Omichi K.; Suzuki R.; Kato-Fukui Y.; Kamiirisa K.; Matsuo M.; Kamijo S.; Kasahara M.; Yoshioka H.; Ogata T.; Fukuda T.; Kondo I.; Kato M.; Dobyns W.B.; Yokoyama M.; Morohashi K.;
Nat. Genet. 32:359-369(2002)
Cited for: FUNCTION; VARIANTS LISX2 HIS-332 AND GLN-343; Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation.
Kato M.; Das S.; Petras K.; Kitamura K.; Morohashi K.; Abuelo D.N.; Barr M.; Bonneau D.; Brady A.F.; Carpenter N.J.; Cipero K.L.; Frisone F.; Fukuda T.; Guerrini R.; Iida E.; Itoh M.; Lewanda A.F.; Nanba Y.; Oka A.; Proud V.K.; Saugier-Veber P.; Schelley S.L.; Selicorni A.; Shaner R.; Silengo M.; Stewart F.; Sugiyama N.; Toyama J.; Toutain A.; Vargas A.L.; Yanazawa M.; Zackai E.H.; Dobyns W.B.;
Hum. Mutat. 23:147-159(2004)
Cited for: FUNCTION; VARIANTS LISX2 PRO-332; HIS-332; GLN-343; ARG-353 AND THR-521; VARIANT ACCAG ASN-333;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.